Singapore | 07 December 2024 | News
BioSpectrum Asia recognises achievements at Excellence Awards 2024 in Singapore on 6 December
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in...Read more
Bio LAB | 01 December 2024 | Analysis
2025 Trends Buoying Boom Phase in APAC
Antibody Drug Conjugates (ADCs) in Stoplight ADCs, touted as ‘magic bullets’ for targeted c...Read more
Artificial Intelligence | 01 December 2024 | Opinion
Sustainability continues to gain significant attention in 2025
From the emergence of recombinant DNA technology in the 1970s to advancements in monoclonal antibodies and lar...Read more
Vietnam | 01 December 2024 | Analysis
How Vietnam is Leveraging AI to Reshape Healthcare
Access Partnership, the world’s leading tech advisory firm, recently presented an economic impact report...Read more
Singapore | 29 November 2024 | Opinion
Unlocking the Innovation Potential in Singapore’s Life Sciences Ecosystem
In October 2023, Johnson & Johnson announced a collaboration with the Singapore Economic Development Board...Read more
BioTech | 01 December 2024 | Opinion
AI’s Future Integration into Clinical Practice: In the coming years, AI will become seamlessly integrate...Read more
Japan | 18 December 2024 | News
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have en...Read more
China | 16 December 2024 | News
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializ...Read more
Korea | 13 December 2024 | News
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from t...Read more
China | 03 December 2024 | News
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved t...Read more
Indonesia | 27 November 2024 | News
India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
SS Innovations, the developer of India’s first indigenous surgical robotic system, dedicated to making a...Read more
Singapore | 19 November 2024 | News
Singapore's SERI and Carl Zeiss invest SG$20 M for driving innovation in ophthalmic surgery
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG, one of the world's leading medical tech...Read more
Korea | 16 December 2024 | News
HiRO forges strategic partnership with CHA University Bundang Medical Center in South Korea
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) p...Read more
Europe | 12 November 2024 | News
Lonza expands Bioconjugation capabilities with two additional manufacturing suites in Switzerland
Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets...Read more
2025 Trends Buoying Boom Phase in APAC
Like many industries, life sciences, too, faced numerous challenges in 2024, such as a slowing economy, and geopolitical conflicts. Despite these headwinds, the sector has shown remarkable resilience, with strong prospects for recovery and growth. Significant investments are being directed toward research and development in key areas such as Antibody Drug Conjugates (ADCs), Cell and Gene Therapies, Artificial Intelligence (AI) and Contract Development and Manufacturing Organisations (CDMOs) and many more. These fields have been major drivers of growth this year and offer promising opportunities. It’s that time of year again when we interact with leaders from major market segments of the industry. These leaders provide their insights into what the coming year is likely to hold for their respective fields. Lets look into a few trends from life sciences that are expected to
make a significant splash in 2025.